1. 1.Boelaert K, Franklyn JA. Thyroid hormone in health and disease. J Endocrinol. 2005 Oct;187(1):1-15. doi: 10.1677/joe.1.06131. PMID: 16214936. [DOI:10.1677/joe.1.06131]

2. Kyritsi EM, Kanaka-Gantenbein C. Autoimmune Thyroid Disease in Specific Genetic Syndromes in Childhood and Adolescence. Front Endocrinol (Lausanne). 2020 Aug 19;11:543. doi: 10.3389/fendo.2020.00543. PMID: 32973676; PMCID: PMC7466763. [DOI:10.3389/fendo.2020.00543] [PMID] []

3. Cvek M, Kaličanin D, Barić A, Vuletić M, Gunjača I, Torlak Lovrić V, Škrabić V, Punda A, Boraska Perica V. Vitamin D and Hashimoto's Thyroiditis: Observations from CROHT Biobank. Nutrients. 2021 Aug 15;13(8):2793. doi: 10.3390/nu13082793. PMID: 34444953; PMCID: PMC8401592. [DOI:10.3390/nu13082793] [PMID] []

4. Pyzik A, Grywalska E, Matyjaszek-Matuszek B, Roliński J. Immune disorders in Hashimoto's thyroiditis: what do we know so far? J Immunol Res. 2015;2015:979167. doi: 10.1155/2015/979167. Epub 2015 Apr 27. PMID: 26000316; PMCID: PMC4426893. [DOI:10.1155/2015/979167] [PMID] []

5. Johnson DS, Chen YH. Ras family of small GTPases in immunity and inflammation. Curr Opin Pharmacol. 2012 Aug;12(4):458-63. doi: 10.1016/j.coph.2012.02.003. Epub 2012 Mar 7. PMID: 22401931; PMCID: PMC3374043. [DOI:10.1016/j.coph.2012.02.003] [PMID] []

6. Tang D, Kroemer G, Kang R. Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges. Mol Cancer. 2021 Oct 4;20(1):128. doi: 10.1186/s12943-021-01422-7. PMID: 34607583; PMCID: PMC8489073. [DOI:10.1186/s12943-021-01422-7] [PMID] []

7. Law SM, Akizuki S, Morinobu A, Ohmura K. A case of refractory systemic lupus erythematosus with monocytosis exhibiting somatic KRAS mutation. Inflamm Regen. 2022 Apr 1;42(1):10. doi: 10.1186/s41232-022-00195-w. PMID: 35361277; PMCID: PMC8973904. [DOI:10.1186/s41232-022-00195-w] [PMID] []

8. Kamisawa T, Tsuruta K, Okamoto A, Horiguchi S, Hayashi Y, Yun X, Yamaguchi T, Sasaki T. Frequent and significant K-ras mutation in the pancreas, the bile duct, and the gallbladder in autoimmune pancreatitis. Pancreas. 2009 Nov;38(8):890-5. doi: 10.1097/MPA.0b013e3181b65a1c. PMID: 19752775. [DOI:10.1097/MPA.0b013e3181b65a1c] [PMID]

9. Gallegos-Arreola MP, García Verdín PM, Magaña-Torres MT, Figuera LE, Zúñiga-González GM, Rosales-Reynoso MA, et al. Association between rs61764370, rs9266, and rs140080026 polymorphisms of the KRAS gene and breast cancer risk in a Mexican population.

10. Eur rev for med and pharm s j. 2021;25(21):6454-64.

11. Zhang SY, Shi J. rs61764370 polymorphism of Kras and risk of cancer in Caucasian population: A meta-analysis. J Cancer Res Ther. 2016 Apr-Jun;12(2):699-704. doi: 10.4103/0973-1482.147379. PMID: 27461636. [DOI:10.4103/0973-1482.147379] [PMID]

12. Uvirova M, Simova J, Kubova B, Dvorackova N, Tomaskova H, Sedivcova M, Dite P. Comparison of the prevalence of KRAS-LCS6 polymorphism (rs61764370) within different tumour types (colorectal, breast, non-small cell lung cancer and brain tumours). A study of the Czech population. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Sep;159(3):466-71. doi: 10.5507/bp.2015.029. Epub 2015 Jun 11. PMID: 26077004. [DOI:10.5507/bp.2015.029] [PMID]

13. Vallejos-Vidal E, Reyes-Cerpa S, Rivas-Pardo JA, Maisey K, Yáñez JM, Valenzuela H, Cea PA, Castro-Fernandez V, Tort L, Sandino AM, Imarai M, Reyes-López FE. Single-Nucleotide Polymorphisms (SNP) Mining and Their Effect on the Tridimensional Protein Structure Prediction in a Set of Immunity-Related Expressed Sequence Tags (EST) in Atlantic Salmon (Salmo salar). Front Genet. 2020 Feb 27;10:1406. doi: 10.3389/fgene.2019.01406. PMID: 32174954; PMCID: PMC7056891. [DOI:10.3389/fgene.2019.01406] [PMID] []

14. Shastry BS. SNPs: impact on gene function and phenotype. Methods Mol Biol. 2009;578:3-22. doi: 10.1007/978-1-60327-411-1_1. PMID: 19768584. [DOI:10.1007/978-1-60327-411-1_1] [PMID]

15. Morita E, Watanabe M, Inoue N, Hashimoto H, Haga E, Hidaka Y, Iwatani Y. Methylation levels of the TNFA gene are different between Graves' and Hashimoto's diseases and influenced by the TNFA polymorphism. Autoimmunity. 2018 May;51(3):118-125. doi: 10.1080/08916934.2018.1448078. Epub 2018 Mar 11. PMID: 29526119. [DOI:10.1080/08916934.2018.1448078] [PMID]

16. Li ZH, Han J, Wang YF, Dai J, Zhang H, Li CX, Ma Q. Association between Polymorphism of Interleukin-23 Receptor and Hashimoto's Thyroiditis in Chinese Han Population of Shandong. Chin Med J (Engl). 2015 Aug 5;128(15):2050-3. doi: 10.4103/0366-6999.161362. PMID: 26228217; PMCID: PMC4717969. [DOI:10.4103/0366-6999.161362] [PMID] []

17. Tabasi F, Hasanpour V, Sarhadi S, Kaykhaei MA, Pourzand P, Heravi M, Langari AA, Bahari G, Taheri M, Hashemi M, Ghavami S. Association of miR-499 Polymorphism and Its Regulatory Networks with Hashimoto Thyroiditis Susceptibility: A Population-Based Case-Control Study. Int J Mol Sci. 2021 Sep 18;22(18):10094. doi: 10.3390/ijms221810094. PMID: 34576267; PMCID: PMC8470033. [DOI:10.3390/ijms221810094] [PMID] []

18. Heidari Z, Salimi S, Rokni M, Rezaei M, Khalafi N, Shahroudi MJ, Dehghan A, Saravani M. Association of IL-1β, NLRP3, and COX-2 Gene Polymorphisms with Autoimmune Thyroid Disease Risk and Clinical Features in the Iranian Population. Biomed Res Int. 2021 Nov 8;2021:7729238. doi: 10.1155/2021/7729238. PMID: 34790822; PMCID: PMC8592725. [DOI:10.1155/2021/7729238] [PMID] []

19. Cerne JZ, Stegel V, Gersak K, Novakovic S. KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study. BMC Cancer. 2012 Mar 22;12:105. doi: 10.1186/1471-2407-12-105. PMID: 22436609; PMCID: PMC3342891. [DOI:10.1186/1471-2407-12-105] [PMID] []

20. Ghazi Jumaa, M. (2022). 'Evaluation of the Role of the KRAS Gene Polymorphism LCS6 (rs61764370) in Iraqi Women with Ovarian Cancer', Archives of Razi Institute, 77(1), pp. 205-211. doi: 10.22092/ari.2021.356992.1956

21. Farokhzad N, Hosseini SM, Edalat H, Sadeghi M. Association of Rs61764370 polymorphism within let-7 microRNA-binding site with lung cancer in Iranian population. Afr Health Sci. 2020 Sep;20(3):1299-1303. doi: 10.4314/ahs.v20i3.35. PMID: 33402978; PMCID: PMC7751538. [DOI:10.4314/ahs.v20i3.35] []

22. Ning L, Rao W, Yu Y, Liu X, Pan Y, Ma Y, Liu R, Zhang S, Sun H, Yu Q. Association between the KRAS Gene Polymorphisms and Papillary Thyroid Carcinoma in a Chinese Han Population. J Cancer. 2016 Dec 9;7(15):2420-2426. doi: 10.7150/jca.16507. PMID: 27994680; PMCID: PMC5166553. [DOI:10.7150/jca.16507] [PMID]

23. Al-Salam S, Sharma C, Afandi B, Al Dahmani K, Al-Zahrani AS, Al Shamsi A, Al Kaabi J. BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates. PLoS One. 2020 Apr 21;15(4):e0231341. doi: 10.1371/journal.pone.0231341. PMID: 32315324; PMCID: PMC7173769. [DOI:10.1371/journal.pone.0231341] [PMID] []